Loss of the Bcl-2 Phosphorylation Loop Domain Increases Resistance of Human Leukemia Cells (U937) to Paclitaxel-Mediated Mitochondrial Dysfunction and Apoptosis
- 27 May 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 259 (1) , 67-72
- https://doi.org/10.1006/bbrc.1999.0669
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of ApoptosisJournal of Biological Chemistry, 1998
- The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating AgentsMolecular Pharmacology, 1997
- Bcl-2 Phosphorylation Required for Anti-apoptosis FunctionJournal of Biological Chemistry, 1997
- Identification of a novel regulatory domain in Bcl-xL and Bcl-2The EMBO Journal, 1997
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell deathNature, 1996
- Phosphorylation of Bcl-2 Protein and Association with p21Ras in Ras-induced ApoptosisJournal of Biological Chemistry, 1996
- Inactivation of Bcl-2 by phosphorylation.Proceedings of the National Academy of Sciences, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Mechanism of action of taxolTrends in Pharmacological Sciences, 1992